Development of Cancer

breast cancer, lower risk and large study links

A large study links GLP-1 use to a 35% lower risk of developing breast cancer

Breast cancer has been the most commonly diagnosed cancer among women worldwide for years running, but GLP-1s may help. The post A Large Study Links GLP-1 Use to a 35% Lower Risk of Developing Breast Cancer appeared first on Secret Life Of Mom.

Science Daily · 2d

· 6h

Blood Test May Predict Lung Cancer Risk 5 Years Before Diagnosis: Study

Science Daily

One fat helped pancreatic cancer grow while another cut disease in half

A surprising new study suggests that when it comes to pancreatic cancer, the kind of fat you eat may matter more than how ...

New pancreatic cancer pill nearly doubles survival time in breakthrough trial

A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 ...

ascopubs.org

Global Cancer Drug Development—A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting

Short-Term Surgical Mission in Sub-Saharan Country, Experience of a Breast-Dedicated Team: Reviewing the Past and Stepping Toward the Last Mission Rapidly expanding systemic treatment options, ...

AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Milestone Ahead of Schedule, Advancing Ampligen Toward Critical Pancreatic Cancer Clinical Milestones

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a significant milestone in its pancreatic cancer development program, with enrollment of the final subject, barring ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results